SCHEMBL23700044

SCHEMBL23700044

CN(C)C(=O)c1cnn2c(=O)cc(-c3ccc([C@@H]4CCCC4(C)C)cc3)[nH]c12

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PLAT P00750 18/20 0.36
SPR P35270 1/20 0.32
JAK1 P23458 1/20 0.32
JAK3 P52333 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23700023 1.00 PLAT (0.36) PLATSPRJAK1JAK3
SCHEMBL23700007 1.00 PLAT (0.36) PLATSPRJAK1JAK3
SCHEMBL23198890 0.90 PLAT (0.41) PLATJAK1JAK3
SCHEMBL29160870 0.85 PLAT (0.48) PLAT
SCHEMBL23198895 0.85 PLAT (0.48) PLAT
SCHEMBL23700031 0.85 PLAT (0.48) PLAT
SCHEMBL23700008 0.85 PLAT (0.39) PLAT
SCHEMBL23700026 0.85 PLAT (0.39) PLAT
SCHEMBL23699993 0.84 HSP90AA1 (0.40) PLAT
SCHEMBL23700022 0.75 PLAT (0.42) PLATSPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112204029-B Therapeutic compounds 豪夫迈·罗氏有限公司 2024-03-01 CN claimed
US-20210238184-A1 THERAPEUTIC COMPOUNDS GENENTECH, INC. (US) 2021-08-05 US claimed
CN-112204029-B Therapeutic compounds 豪夫迈·罗氏有限公司 2024-03-01 CN disclosed
US-20210238184-A1 THERAPEUTIC COMPOUNDS GENENTECH, INC. (US) 2021-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210238184-A1 THERAPEUTIC COMPOUNDS YAP1, YES1, KRAS PLAT 3945/4885SPR 1589/4885JAK1 437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.